|
1
|
Hildesheim A and Levine PH: Etiology of
nasopharyngeal carcinoma: A review. Epidemiol Rev. 15:466–485.
1993.PubMed/NCBI
|
|
2
|
Feng BJ, Huang W, Shugart YY, Lee MK,
Zhang F, Xia JC, Wang HY, Huang TB, Jian SW, Huang P, et al:
Genome-wide scan for familial nasopharyngeal carcinoma reveals
evidence of linkage to chromosome 4. Nat Genet. 31:395–399.
2002.PubMed/NCBI
|
|
3
|
Sobin LH and Fleming ID: Union
Internationale Contre le Cancer and the American Joint Committee on
Cancer: TNM classification of malignant tumors, fifth edition
(1997). Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L,
Pan Q, He ML and Li XP: MicroRNA-10b induced by Epstein-Barr
virus-encoded latent membrane protein-1 promotes the metastasis of
human nasopharyngeal carcinoma cells. Cancer Lett. 299:29–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wong TS, Man OY, Tsang CM, Tsao SW, Tsang
RK, Chan JY, Ho WK, Wei WI and To VS: MicroRNA let-7 suppresses
nasopharyngeal carcinoma cells proliferation through downregulating
c-Myc expression. J Cancer Res Clin Oncol. 137:415–422. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xia H, Ng SS, Jiang S, Cheung WK, Sze J,
Bian XW, Kung HF and Lin MC: miR-200a-mediated downregulation of
ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma
cell growth, migration and invasion. Biochem Biophys Res Commun.
391:535–541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li
JJ, Röcken C, Ebert MP, Kwok TT and Sung JJ: MicroRNA-143 targets
DNA methyltransferases 3A in colorectal cancer. Br J Cancer.
101:699–706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takagi T, Iio A, Nakagawa Y, Naoe T,
Tanigawa N and Akao Y: Decreased expression of microRNA-143 and
−145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Osaki M, Takeshita F, Sugimoto Y, Kosaka
N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T,
et al: MicroRNA-143 regulates human osteosarcoma metastasis by
regulating matrix metalloprotease-13 expression. Mol Ther.
19:1123–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Noguchi S, Yasui Y, Iwasaki J, Kumazaki M,
Yamada N, Naito S and Akao Y: Replacement treatment with
microRNA-143 and −145 induces synergistic inhibition of the growth
of human bladder cancer cells by regulating PI3K/Akt and MAPK
signaling pathways. Cancer Lett. 328:353–361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Sun Q, Zhang Z, Ge S, Han ZG and
Chen WT: Loss of microRNA-143/145 disturbs cellular growth and
apoptosis of human epithelial cancers by impairing the MDM2-p53
feedback loop. Oncogene. 32:61–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Liu S, Hu T, Liu S, He Y and Sun
S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B
enhances hepatocarcinoma metastasis by repressing fibronectin
expression. Hepatology. 50:490–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu YF, Li YQ, Guo R, He QM, Ren XY, Tang
XR, Jia WH, Kang TB, Zeng MS, Sun Y, et al: Identification of
miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on
microRNA expression profiling. Int J Biochem Cell Biol. 61:120–128.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clapé C, Fritz V, Henriquet C, Apparailly
F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S and
Fajas L: miR-143 interferes with ERK5 signaling, and abrogates
prostate cancer progression in mice. PloS One. 4:e75422009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu L, Yu X, Guo X, Tian Z, Su M, Long Y,
Huang C, Zhou F, Liu M, Wu X and Wang X: miR-143 is downregulated
in cervical cancer and promotes apoptosis and inhibits tumor
formation by targeting Bcl-2. Mol Med Rep. 5:753–760.
2012.PubMed/NCBI
|
|
20
|
Zhang Y, Wang Z, Chen M, Peng L, Wang X,
Ma Q, Ma F and Jiang B: MicroRNA-143 targets MACC1 to inhibit cell
invasion and migration in colorectal cancer. Mol Cancer. 11:232012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng X, Guo W, Liu T, Wang X, Tu X, Xiong
D, Chen S, Lai Y, Du H, Chen G, et al: Identification of miRs-143
and −145 that is associated with bone metastasis of prostate cancer
and involved in the regulation of EMT. PloS One. 6:e203412011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hiyoshi Y, Kamohara H, Karashima R, Sato
N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M
and Baba H: MicroRNA-21 regulates the proliferation and invasion in
esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Borralho PM, Simões AE, Gomes SE, Lima RT,
Carvalho T, Ferreira DM, Vasconcelos MH, Castro RE and Rodrigues
CM: miR-143 overexpression impairs growth of human colon carcinoma
xenografts in mice with induction of apoptosis and inhibition of
proliferation. PLoS One. 6:e237872011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X, Guo X, Zhang H, Xiang Y, Chen J,
Yin Y, Cai X, Wang K, Wang G, Ba Y, et al: Role of miR-143
targeting KRAS in colorectal tumorigenesis. Oncogene. 28:1385–1392.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Cai X, Wang Y, Tang H, Tong D and
Ji F: microRNA-143, down-regulated in osteosarcoma, promotes
apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol
Rep. 24:1363–1369. 2010.PubMed/NCBI
|
|
27
|
Liu R, Liao J, Yang M, Sheng J, Yang H,
Wang Y, Pan E, Guo W, Pu Y, Kim SJ and Yin L: The cluster of
miR-143 and miR-145 affects the risk for esophageal squamous cell
carcinoma through co-regulating fascin homolog 1. PloS One.
7:e339872012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu BL, Xu LY, Du ZP, Liao LD, Zhang HF,
Huang Q, Fang GQ and Li EM: MiRNA profile in esophageal squamous
cell carcinoma: Downregulation of miR-143 and miR-145. World J
Gastroenterol. 17:79–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Drew BA, Burow ME and Beckman BS:
MEK5/ERK5 pathway: The first fifteen years. Biochim Biophys Acta.
1825:37–48. 2012.PubMed/NCBI
|
|
30
|
Lochhead PA, Gilley R and Cook SJ: ERK5
and its role in tumour development. Biochem Soc Trans. 40:251–256.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ni Y, Meng L, Wang L, Dong W, Shen H, Wang
G, Liu Q and Du J: MicroRNA-143 functions as a tumor suppressor in
human esophageal squamous cell carcinoma. Gene. 517:197–204. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Esau C, Kang X, Peralta E, Hanson E,
Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R, et
al: MicroRNA-143 regulates adipocyte differentiation. J Biol Chem.
279:52361–52365. 2004. View Article : Google Scholar : PubMed/NCBI
|
